Acrônimos - P

PACE
Prevention by low dose Aspirin of Cardiovascular disease in the Elderly
PACK
Prevention of Atherosclerotic Complications with Ketanserin
PAMELA
Pressioni AMbulatoriali E Loro Associazioni
PAMI
Primary Angioplasty in Myocardial Infarction trial
PAMI-2
second Primary Angioplasty in Myocardial Infarction
PART
Probucol Angioplasty Restenosis Trial
PART-2
Prevention of Atherosclerosis with Ramipril
PASE
PAcemaker Selection in the Elderly trial
PASS
Practical Applicability of Saruplase Study
PATAF
Primary prevention of Arterial Thromboembolism in patients with non-rheumatic Atrial Fibrillation in general practice
PEACE
Prevention of Events with Angiotensin Converting Enzyme Inhibition
PEP
Pulmonary Embolism Prevention trial
PEPI
Postmenopausal Estrogen/Progestin Interventions
PHYLLIS
Plaque Hypertension Lipid-Lowering Italian Study
PLAC I
Pravastatin to Limit Atherosclerosis in the Coronary arteries
PLAC II
Pravastatin, Lipids, and Atherosclerosis in the Carotid arteries II
PLUR
Praxisblutdruckmessung versus Langzeitblutdruckmessung Unter der therapie mit Ramipril
PQRST
Probucol Quantitative Regression Swedish Trial
PRACTICAL
Placebo-controlled, Randomized, ACE inhibitor, Comparative Trial In Cardiac Infarction and LU function
PRAISE I
Prospective Randomised Amlodipine Survival Evaluation I
PRAISE II
Prospective Randomised Amlodipine Survival Evaluation II
PRAISE
Prospective Randomized AmlodIpine Survival Evaluation
PRECISE
Prospective Randomized Evaluation of CarvedIlol on Symptoms and Exercise
PREDICT
Prevention des Restenoses par Elisor apres Dilatation Coronaire Transluminale
PREPIC
Prevention du Risque d'Embolie Pulmonaire par Interruption Cave
PRESANCE
Privention de la REStinose prhs ANgioplastie Coronaire silectivE
PRESERVE
Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement
PREVENT
Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial
PRIME II
Prospective Randomised study of Ibopamine on Mortality and Efficacy II
PRIMI
PRo-urokinase In Myocardial Infarction trial
PRISM
Platelet Receptor Inhibition for Ischemic Syndrome Management
PRISM-PLUS
Platelet Receptor Inhibiton for Ischemic Syndrome Management in Patients Limited to Very Unstable Signs and Symptoms
PROCAM
Prospective Cardiovascular Münster Heart Study
PROGRESS
Perindopril Protection Against Recurrent Stroke Study
PROMISE
Prospective RandOmized MIlrinone Survival Evaluation trial
PROTECT
Perindopril Regression of Vascular Thickening European Community Trial
PURSUIT
Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy trial
PUTS
Perindopril Therapeutic Safety Study

Apoio: Farmacêutica